Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Operating Leases: 2022-2025

Historic Operating Leases for NewGenIvf (NIVF) over the last 4 years, with Sep 2025 value amounting to $298.1 billion.

  • NewGenIvf's Operating Leases was N/A to $298.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $298.1 billion, marking a year-over-year change of. This contributed to the annual value of $10,231 for FY2024, which is 91.40% down from last year.
  • As of Q3 2025, NewGenIvf's Operating Leases stood at $298.1 billion, which was up 100,033,794.89% from $297,980 recorded in Q2 2025.
  • In the past 5 years, NewGenIvf's Operating Leases registered a high of $298.1 billion during Q3 2025, and its lowest value of $10,231 during Q4 2024.
  • Moreover, its 3-year median value for Operating Leases was $208,480 (2023), whereas its average is $74.5 billion.
  • In the last 5 years, NewGenIvf's Operating Leases surged by 50.87% in 2023 and then plummeted by 91.40% in 2024.
  • MRQ analysis of 4 years shows NewGenIvf's Operating Leases stood at $242,187 in 2022, then crashed by 50.87% to $118,979 in 2023, then plummeted by 91.40% to $10,231 in 2024, then skyrocketed by 2,913,507,865.99% to $298.1 billion in 2025.
  • Its Operating Leases stands at $298.1 billion for Q3 2025, versus $297,980 for Q2 2025 and $10,231 for Q4 2024.